Mark Sabag sold $2.9M of Teva Pharmaceutical Industries Limited (TEVA)

Executed Feb 12 2025, disclosed Feb 14 2025, 2 days later.

Value, as filed

$2.9M

177,626 sh × $16.25

Executed

Feb 12 2025

the trade date, as filed

Disclosed

Feb 14 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Mark Sabag See "Remarks" profile →

Mark Sabag (See "Remarks") filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Teva Pharmaceutical Industries Limited (TEVA). The largest single filing was $6.2M of TEVA (216,892 sh across 2 lots, as filed), executed Dec 9 2025.

The name

TEVA

Teva Pharmaceutical Industries Limited TEVA · Healthcare · 56 filings in 24 months ticker →

Healthcare · Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Mark Sabag in TEVA

TEVASALE Teva Pharmaceutical Industries Limited $5.0M
144,180 sh × $34.99
Exec May 1
Filed May 4 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited $1.9M
62,102 sh × $30.14
Exec Mar 17
Filed Mar 19 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited $6.2M
216,892 sh across 2 lots
Exec Dec 9 2025
Filed Dec 11 2025 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited $6.1M
337,915 sh × $18.04
Exec May 8 2025
Filed May 12 2025 · 5:30 PM ET